Description
Advances in Pharma Business Management and Research, 1st ed. 2020
Volume 1
Coordinators: Schweizer Lars, Dingermann Theodor, Russe Otto Quintus, Jansen Christian
Language: EnglishSubjects for Advances in Pharma Business Management and Research:
Publication date: 09-2020
Support: Print on demand
Publication date: 02-2020
85 p. · 15.5x23.5 cm · Hardback
Description
/li>Contents
/li>Biography
/li>Comment
/li>
This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'.
The chapters are summaries of master?s theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business.Dr. Lars Schweizer
Prof. Dr. Lars Schweizerhas been a Professor of Strategic Management at Goethe University Frankfurt since December 2007. Currently, he is the Academic Director of the Master of Pharma Business Administration as well as the Master of Digital Transformation at Goethe Business School. He holds a doctoral degree and postdoctoral degree (habilitation) from the University of Bamberg. He has published papers in journals such as the Academy of Management Journal, the Strategic Management Journal, the Journal of Management, Industrial and Corporate Change, the Journal of General Management, Scandinavian Journal of Management, the Journal of Engineering and Technology Management, the International Journal of Biotechnology, Pharmaceutical Policy and Law, and the Journal of Business Research. His main research focuses are mergers & acquisitions, strategic management, leadership, and organizational behavior as well as the pharmaceutical and biotechnology industries.
Dr. Theodor Dingermann
Prof. Dr. rer. nat. Theodor Dingermann (1948) studied Pharmacy at the University of Erlangen-Nurnberg between 1973 and 1976. In 1980 he received his Ph.D. in Biochemistry. From 1980 to 1982 he worked as a postdoctoral fellow at Yale University, New Haven, USA with Prof. Dr. Dieter Söll. From 1990 to 2013 he was a Professor and Director of the Department of Pharmaceutical Biology at Goethe University Frankfurt/Main. Since 2013 he has been affiliated with the Goethe University as a Senior Professor. Prof. Dingermann received the Carl-Mannich-Medal Award from the German Pharmaceutical Society in 2010, and he was elected “Professor of the Year 2009” in Germany. He is editor-in-chief of the international scientific journal DIE PHARMAZIE, editor-in-chief of “Pharmakon”, the official journal of the German Pharmaceutical Society, and a member of the group of chiefedit